Chemed (CHE) Cash from Financing Activities (2009 - 2026)

Chemed has reported Cash from Financing Activities for 18 years, with the latest figure at -$33.2 million in Q2 2026.

• Cash from Financing Activities for Q2 2026 came in at -$33.2 million, up 29.5% year-over-year; the trailing twelve-month figure through Jun 2026 was -$503.4 million (down 48.25% YoY), and the FY2025 annual result was -$432.8 million, down 20.48% from the prior year.
• Cash from Financing Activities climbed to -$33.2 million in Q2 2026, from -$108.1 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at -$263000.0 in Q3 2023 and troughed at -$212.5 million in Q4 2024.
• A 5-year average of -$67.9 million and a median of -$50.3 million in 2022 frame the typical range for Cash from Financing Activities.
• The widest annual swing landed in 2023, when Cash from Financing Activities soared 99.34%; it then slumped 21365.02% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$14.4 million in 2022, then jumped by 57.64% to -$6.1 million in 2023, then sank by 3392.1% to -$212.5 million in 2024, then increased by 18.67% to -$172.8 million in 2025, then surged by 80.78% to -$33.2 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$33.2 million in Q2 2026, -$108.1 million in Q1 2026, and -$172.8 million in Q4 2025.